L1CAM drives UCEC aggressiveness by promoting tumor invasion, drug-resistance and metastasis, and therefore in both high- and low-risk diseases, high L1CAM expression is associated with recurrence and/or local and distant metastasis, and poor outcomes (Giannini et al., 2024). This evidence concerns the gene L1CAM and neoplasm.